lightrock I came to the same conclusion a while ago The "futile" came from this unblinded data, but the data set was way way too small for a descent statistics and the time elapsed way to short to draw conclusions on events-based survival. Therefore I think they worried more about safety than efficacy.. Or they had a double agenda paid by nasty big pharma...
News 
Market Data 
Discover 
